Claude Franceschi: Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Claude Franceschi, Angiologist Consultant Teacher at Center Marie‑Thérèse, shared a post on LinkedIn about a recent article by Jinghe Zhu et al, published in Annals of Vascular Surgery:
“Preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, is possible with CHIVA.
Systematic review and meta-analysis comparing the efficacy of CHIVA and conventional stripping and ablation techniques
Objective: Chronic venous disease (CVD), particularly primary lower extremity varicose veins, is a prevalent global health issue. The CHIVA technique is a hemodynamic-based, vein-preserving strategy proposed as a minimally invasive alternative to traditional treatments such as high ligation and stripping (HLS) or endovenous thermal ablation (e.g., radiofrequency or laser).
The CHIVA technique is designed to treat varicose veins while preserving the great saphenous vein (GSV), which is the first-choice conduit for potential future arterial grafting, especially at the infra-inguinal level. It offers theoretical advantages of reduced trauma, fewer complications, and lower recurrence potential. This systematic review aims to evaluate the efficacy and safety of CHIVA relative to established techniques based on current evidence.”
Title: Systematic Review and Meta-Analysis Comparing the Efficacy of CHIVA and Conventional Stripping and Ablation Techniques
Authors: Jinghe Zhu, Hongjie Cui, Menglong Li, Yingfeng Wu
Read the Full Article on Annals of Vascular Surgery․
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 21, 2026, 15:02Sham Zamil: The Role of ABO Compatibility in Platelet Pooling
-
Jul 21, 2026, 13:43Dima Shulkin: Assessing AI-Driven Blood Test Screening for Colorectal Cancer
-
Jul 21, 2026, 13:24Benoit Mores: National Initiative Targets Better Cardiovascular Outcomes
-
Jul 21, 2026, 13:10Paolo Zamboni: Chronic Cerebrospinal Venous Insufficiency Hypothesis in Multiple Sclerosis
-
Jul 21, 2026, 13:05Danai Poutakidou։ The Diagnostic Pitfalls of Unexpected PT/INR Prolongation
-
Jul 21, 2026, 13:00Kefah Mokbel: Beyond Thromboprophylaxis – Enoxaparin’s Emerging Anticancer Signal
-
Jul 21, 2026, 12:56Emmanuel Velazquez-Alvarez: Bridging Innovation and Clinical Practice
-
Jul 21, 2026, 12:53Sandrine Bouteille: A Milestone Presentation at ISTH 2026
-
Jul 21, 2026, 12:40Kalled Musallam: A Comprehensive Review of Thalassemia